| All news about INTERCEPT PHARMACEUTICALS, INC. |
|
|
|
|
|
| Analyst Recommendations on INTERCEPT PHARMACEUTICALS, INC. |
|
|
|
|
|
|
| Auctions for 2022 |
316 M
–
–
|
| Total revenue for 2022 |
35.8 M
–
–
|
| Balance for 2022 |
61.9 m
–
–
|
| P/E ratio 2022 |
29, 9x |
| 2022 harvest |
– |
|
| Capitalization |
768 m
768 m
–
|
| EV / Sales 2022 |
2.23x |
| EV / Sales 2023 |
2.35x |
| Nbr of employees |
437 |
| Free-Float |
96.8% |
|
| Chart INTERCEPT PHARMACEUTICALS, INC. |
|
Time frame :
Time :
|
 |
|
|
Technical analysis trends INTERCEPT PHARMACEUTICALS, INC.
|
Short term |
In the meantime |
Long term |
| Trends |
Bullish |
Neutrality |
Neutrality |
Income Statement Evolution
|
|
| It means compromise |
HOLD ON |
| No. of Analysts |
16 |
| Final Closing Amount |
$18.55 |
| Average target value |
22,50 $ |
| Distribution Target / Rate |
21.3% |
|
Source link
